Press Releases

Aperio Announces European Digital Pathology Science Seminar Series

Program to Feature Pathology Leaders from Leading Pharmaceutical Companies

Vista, CA – February 18, 2008 - Aperio Technologies, Inc., (Aperio), a global leader in digital pathology for the healthcare and life sciences industry invites interested pathology professionals in Europe to join them for their new seminar series to be held in early March, 2008 at select locations. The one day local events will be offered free of charge, and are designed to bring pathology, biology, and histology attendees together to learn new techniques for working with whole slide digital pathology images.

The seminar series will be offered on the following dates, at three convenient locations:

  • 3rd March 2008: Sir James Black Conference Center
    AstraZeneca, Alderly Edge, Macclesfield, Cheshire, UK

  • 5th March 2008: Lindner Hotel, Frankfurt, Germany

  • 7th March 2008: Swissotel Le Plaza, Basel, Switzerland
Each seminar will feature leading pharmaceutical industry professionals as well as Aperio scientists, and will discuss how digital pathology is used in discovery, preclinical, and clinical trials environments. The program will feature the following speakers from the pathology industry:
  • Frank Voelker, D.V.M., DACVP (retired, Novartis), presenting “Image Analysis in Toxicological Pathology” AstraZeneca, Alderly Edge, Macclesfield, Cheshire, UK

  • Alison Bigley CSci, FIBMS AstraZeneca, presenting “Image Data Management in Discovery; AstraZeneca Experiences

  • Jason Hill, Ph.D. Director Molecular Biology, Targeted Molecular Diagnostics, presenting “Image Analysis with Phosphorylation and Cytoplasm Protein Biomarkers in Phase 1 Oncology Clinical Trials Dosing Studies”

  • Steve Potts, Ph.D., Director, Biopharma, Aperio, presenting “Use of Microvessel Analysis for Angiogenesis Applications” and “Scanner and Pathologist Precision in Immunohistochemistry Analysis: Results of a Multisite Study with 240 ER, PR and HER2 Slides”

  • Steven Hashagen, Software Manager, Tissue Microarrays, Aperio, presenting “Setting up Spectrum Plus in Toxicological Pathology Environments”
Attendees will also have an opportunity to network and discuss key research issues and best practices with Aperio experts and other scientists. Registration will include a free lunch and cocktail hour, and software demonstrations of Aperio’s digital pathology system.

To register, please email Bethan@aperio.com. Questions may be directed to the Aperio UK team at +44 1275 375123, or by emailing Bethan@aperio.com.

About Aperio Technologies

Aperio is digitizing pathology. We provide systems and services for digital pathology, which is a digital environment for the management and interpretation of pathology information that originates with a digital slide. Aperio’s award-winning ScanScope slide scanning systems and Spectrum™ digital pathology information management software improve the efficiency and quality of pathology services for pathologists and other professionals. Applications include education, remote viewing, archival and retrieval, basic research, and image analysis. Aperio’s products are intended for research and education use only. For more information, please visit www.aperio.com.

Contacts:

Peter Rogan
Director, European Sales
Aperio
011.44.1275.375.123
progan@aperio.com

Kevin Whiteley
Vice President, Marketing
Aperio
760.539.1177
kwhiteley@aperio.com

Myla Wagner
Myla Wagner Public Relations
925.736.7515
myla@mylawagnerpr.com

back to Press Releases

* Aperio products are FDA cleared for specific clinical applications, and are intended for research use for other applications.